Bank Of New York Mellon Corp Rezolute, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.38 - $2.84 $37,243 - $76,645
26,988 New
26,988 $55,000
Q3 2022

Nov 14, 2022
SELL
$2.19 - $3.49 $2,222 - $3,542
-1,015 Reduced 3.72%
26,236 $72,000
Q2 2022

Aug 15, 2022
BUY
$2.6 - $3.85 $70,852 - $104,916
27,251 New
27,251 $88,000

Others Institutions Holding RZLT

# of Institutions
62
Shares Held
38.5M
Call Options Held
1.6K
Put Options Held
24.6K
View Full List

About Rezolute, Inc.

RZLT Quotes by TradingView
  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $172M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email